Queen Mary University of London: Single Daily Pill Shows Promise as Replacement for Complex, Multi-tablet HIV Treatment Regimens
February 26, 2026
February 26, 2026
LONDON, England, Feb. 26 (TNSjou) -- Queen Mary University of London issued the following news:
* * *
Single daily pill shows promise as replacement for complex, multi-tablet HIV treatment regimens
A phase 3 clinical trial, led by Professor Chloe Orkin of Queen Mary University of London, has shown that a new, daily oral tablet that combines two current HIV treatment medications - bictegravir and lenacapavir (BIC/LEN) - may simplify treatment significantly f . . .
* * *
Single daily pill shows promise as replacement for complex, multi-tablet HIV treatment regimens
A phase 3 clinical trial, led by Professor Chloe Orkin of Queen Mary University of London, has shown that a new, daily oral tablet that combines two current HIV treatment medications - bictegravir and lenacapavir (BIC/LEN) - may simplify treatment significantly f . . .